Eye Health News and Research

Latest Eye Health News and Research

Researchers develop computer program to accurately simulate protein folding

All proteins self-assemble in a fraction of the blink of an eye, but it can take a long time to mimic the process. And there has been no guarantee of success, even with the most powerful computers - until now.

8 Jul 2010

ISCO and Sankara Nethralaya collaborate to develop "CytoCor" stem cell-derived corneal tissue

International Stem Cell Corporation and Sankara Nethralaya, announced today commencement of a collaboration to develop ISCO's "CytoCor™" stem cell-derived corneal tissue. The goal is to use CytoCor to treat corneal blindness and vision impairment. "This is one more step in ISCO's stated plan of building its portfolio of therapeutic agents through strategic alliances throughout the world," said Chairman, Ken Aldrich.

7 Jul 2010

New study may lead to in-car warning system that may provide enough time for drivers to react

It is well-documented that when negotiating winding roads, drivers tend to look at a specific, well-defined point on the lane marking - referred to as the tangent point. New research finds that the further drivers can look ahead, generally in left-hand curves, wide curves and when leaving a curve, the less they have to look at the tangent point.

7 Jul 2010

Predictable, preventable injuries occur in children during summer months, say doctors

It is a time most families look forward to every year - summertime. For parents, the warm summer months are often filled with family vacations and cookouts. For kids, it is a chance to play outdoors and enjoy a few months without homework. However, doctors at Nationwide Children's Hospital have recently noticed a trend in injuries that occur in children during the summer months that are both predictable and preventable.

7 Jul 2010

Carrots can help protect vision, not improve

In a recent survey among eyecare providers, nearly 30 percent hear the following question at least once a week: Will eating carrots really improve my vision?

7 Jul 2010

FDA approves IMT to improve vision in patients with end-stage AMD

The U.S. Food and Drug Administration today announced it has approved the Implantable Miniature Telescope to improve vision in some patients with end-stage age-related macular degeneration.

7 Jul 2010

Shire receives FDA approval of Daytrana for ADHD in adolescents

Shire plc, the global specialty biopharmaceutical company, announced the US Food and Drug Administration (FDA) approval of Daytrana® (methylphenidate transdermal system) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents aged 13 to 17 years. Daytrana, the first and only transdermal ADHD patch, is already an FDA-approved ADHD treatment for children 6 to 12 years. Daytrana is indicated as an integral part of a total treatment program for ADHD that may include other measures (psychological, educational, and social).

7 Jul 2010

Phase Ia clinical trial of SYL040012 for treating elevated intraocular pressure, glaucoma completed

Sylentis, a biopharmaceutical subsidiary of Grupo Zeltia and a pioneer in the research and development of new drugs based on gene silencing (interference RNA, RNAi), has completed Phase Ia of its first clinical trial with SYL040012 in the form of ophthalmic drops to treat elevated intraocular pressure and glaucoma.

7 Jul 2010

Fera Pharmaceuticals launches Neptazanetm tablets for reducing intraocular pressure

Fera Pharmaceuticals is pleased to announce the launch of Neptazane (Methazolamide) 25 mg and 50 mg tablets. Both strengths are available in 90 count bottles.

3 Jul 2010

Monroe Carell Jr. Children's Hospital issues public safety warning about dangers of swimming pools

A strong public safety warning about the dangers of swimming pools comes in the wake of 19 drownings or near-drownings treated by doctors at the Monroe Carell Jr. Children's Hospital at Vanderbilt since May 27.

3 Jul 2010

Genes can predict longevity with 77% accuracy: Study

In an analysis of genes of more than 1,000 centenarians, American researchers have come to the conclusion that genes play a large role in completing a century in life. The research team studied 1,055 Caucasians born between 1890 and 1910 and compared them with 1,267 people born later. They claim that there are signatures in the genetic makeup of these people that have a possible link with their longevity.

2 Jul 2010

Healthy diet can reduce age-related eye problems

While 20/20 vision is a symbol of visual acuity, between now and the year 2020, more and more people will experience some extent of vision loss due to age-related macular degeneration (AMD) and other sight-robbing diseases.

2 Jul 2010

ThromboGenics to present microplasmin Phase III trial data at 28th ASRS and 10th EURETINA Congress

ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, announces that data from the second Phase III trial of microplasmin (TG-MV-007) for the non-surgical treatment of vitreomacular adhesion (VMA), are to be presented at the 28th Annual Meeting of the American Society of Retina Specialists (ASRS) and the 10th EURETINA Congress.

1 Jul 2010

Research findings suggest new treatment approach to improve corneal transplants

Although it is already one of medicine's most successful transplant procedures, doctors continue to seek ways to improve corneal transplants. Now, for the first time, a team of German and British researchers have confirmed that failure and rejection of transplanted corneas are more likely in patients whose eyes exhibit abnormal vessel growth, called corneal neovascularization, prior to surgery.

1 Jul 2010

pSivida's licensee submits NDA to FDA for Iluvien

pSivida Corp., a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, today announced that its licensee, Alimera Sciences has submitted a New Drug Application to the U.S. Food and Drug Administration for Iluvien for Diabetic Macular Edema.

1 Jul 2010

Medtronic's sensor-augmented insulin pump therapy provides superior glucose control, confirms STAR 3 study

In the longest and largest randomized, controlled study of sensor-augmented insulin pump therapy in type 1 diabetes, adult and pediatric patients using the Medtronic MiniMed Paradigm® REAL-Time System achieved better glucose control without an increase in hypoglycemia compared to multiple daily insulin injections (MDI), the most common approach to care today.

30 Jun 2010

InNexus develops IXS312 small protein fragment as topical therapy for AMD, diabetic retinal dysplasia

InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced that it has developed IXS312(VEGF), an antibody fragment with activity against the growth factor VEGF for planned use in ocular treatments.

30 Jun 2010

Study: Near-normal glucose control does not delay risk of organ damage in diabetes patients

In people with longstanding type 2 diabetes who are at high risk for heart attack and stroke, lowering blood sugar to near-normal levels did not delay the combined risk of diabetic damage to kidneys, eyes, or nerves, but did delay several other signs of diabetic damage, a study has found. The intensive glucose treatment was compared with standard glucose control.

30 Jun 2010

Study highlights importance of individualized, patient-centered therapies

In an analysis from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, one of the largest studies of its kind to determine whether intensive blood glucose (sugar) control worked better than standard blood sugar control among diabetics, results show that the benefits of intensive therapy need to be balanced against the increase in total and cardiovascular disease-related death, increased weight gain, and high risk for severe low blood sugar.

30 Jun 2010

Vivakor completes phase I SBIR research grant, submits final report to National Eye Institute

Vivakor, Inc. today announced the completion of its phase one SBIR research grant and submission of its final report to the National Eye Institute of the National Institutes of Health. Research from this grant will be used to improve Vivakor's VivaSight technologies and imaging performance of its Digital Photo Refractor device.

30 Jun 2010

Eye Health News and Research

Latest Eye Health News and Research

Researchers develop computer program to accurately simulate protein folding

ISCO and Sankara Nethralaya collaborate to develop "CytoCor" stem cell-derived corneal tissue

New study may lead to in-car warning system that may provide enough time for drivers to react

Predictable, preventable injuries occur in children during summer months, say doctors

Carrots can help protect vision, not improve

FDA approves IMT to improve vision in patients with end-stage AMD

Shire receives FDA approval of Daytrana for ADHD in adolescents

Phase Ia clinical trial of SYL040012 for treating elevated intraocular pressure, glaucoma completed

Fera Pharmaceuticals launches Neptazanetm tablets for reducing intraocular pressure

Monroe Carell Jr. Children's Hospital issues public safety warning about dangers of swimming pools

Genes can predict longevity with 77% accuracy: Study

Healthy diet can reduce age-related eye problems

ThromboGenics to present microplasmin Phase III trial data at 28th ASRS and 10th EURETINA Congress

Research findings suggest new treatment approach to improve corneal transplants

pSivida's licensee submits NDA to FDA for Iluvien

Medtronic's sensor-augmented insulin pump therapy provides superior glucose control, confirms STAR 3 study

InNexus develops IXS312 small protein fragment as topical therapy for AMD, diabetic retinal dysplasia

Study: Near-normal glucose control does not delay risk of organ damage in diabetes patients

Study highlights importance of individualized, patient-centered therapies

Vivakor completes phase I SBIR research grant, submits final report to National Eye Institute

Genetics & Genomics - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Eye Health News and Research

Latest Eye Health News and Research

Genetics & Genomics - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in